Schedule 13G ownership disclosure

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Security class unavailable · CUSIP: 539319103

Event date: 2017-02-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.3500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-17-003796
Form type
SC 13G
Filer
Bahl Lalit Rai
CIK
CIK 1703504
Filed
Apr 13, 2017
Reporting period
Feb 24, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub